Clinical Trial Update: Safety and Tolerability of Seroguard Use [Phase 1]

View source ↗

Summary

Phase 1 trial update on safety and tolerability of Seroguard in adhesion indications; completed with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adhesion

Drugs mentioned

• Seroguard

Snippet

Sponsor: Pharmasyntez | Conditions: Adhesion | Phase 1 | Status: COMPLETED | Results posted: 2019-05-03